XML 100 R74.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Derivative Instruments (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Mar. 31, 2022
Derivatives [Line Items]            
Unrealized Gain on Derivatives     $ 12.9 $ 0.0    
Unrealized Loss on Derivatives     (9.5) (34.8)    
Unrealized Gain (Loss) on Derivatives     3.4 (34.8)    
Foreign Currency Cash Flow Hedge Gain (Loss) To Be Reclassified During Next 15 Months $ 3.4   3.4      
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months 1.9   1.9      
Gain (loss) on foreign currency derivative instruments not designated as hedging instruments $ (5.7) $ 7.2 $ (30.0) 5.4    
Minimum            
Derivatives [Line Items]            
Range of durations of foreign currency forward contracts 1 month   1 month   1 month  
Maximum            
Derivatives [Line Items]            
Range of durations of foreign currency forward contracts 15 months   15 months   12 months  
Not designated as hedging instrument            
Derivatives [Line Items]            
Derivative, Notional Amount $ 1,199.3   $ 1,199.3   $ 1,301.5  
Other current assets | Designated as hedging instrument            
Derivatives [Line Items]            
Derivative asset, fair value 17.6   17.6   0.3  
Other current assets | Not designated as hedging instrument            
Derivatives [Line Items]            
Derivative asset, fair value 5.8   5.8   11.6  
Accrued expenses and other | Designated as hedging instrument            
Derivatives [Line Items]            
Derivative liability, fair value 8.3   8.3   26.5  
Accrued expenses and other | Not designated as hedging instrument            
Derivatives [Line Items]            
Derivative liability, fair value 10.3   10.3   5.1  
Other noncurrent assets | Designated as hedging instrument            
Derivatives [Line Items]            
Derivative asset, fair value 1.8   1.8   0.0  
Foreign exchange contract | Designated as hedging instrument            
Derivatives [Line Items]            
Derivative, Notional Amount 1,658.5   1,658.5   1,169.0  
Revenue | Foreign exchange contract            
Derivatives [Line Items]            
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax 7.6 2.4 10.5 20.0    
Revenue | Cash flows, revenue | Foreign exchange contract            
Derivatives [Line Items]            
Gain on interest rate swap 0.9 (1.0) 1.1 0.6    
Operating expense | Foreign exchange contract            
Derivatives [Line Items]            
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax (4.9) 1.4 (7.0) 0.9    
Operating expense | Cash flows, operating expenses | Foreign exchange contract            
Derivatives [Line Items]            
Gain on interest rate swap (0.7) $ (0.8) (1.9) $ (2.9)    
Euro | Foreign exchange contract | Designated as hedging instrument            
Derivatives [Line Items]            
Derivative, Notional Amount 1,420.3   1,420.3   1,169.0  
Swiss franc | Foreign exchange contract | Designated as hedging instrument            
Derivatives [Line Items]            
Derivative, Notional Amount 69.6   69.6   0.0  
Japan, Yen | Foreign exchange contract | Designated as hedging instrument            
Derivatives [Line Items]            
Derivative, Notional Amount 26.2   26.2   0.0  
Canadian dollar | Foreign exchange contract | Designated as hedging instrument            
Derivatives [Line Items]            
Derivative, Notional Amount $ 142.4   $ 142.4   $ 0.0  
Samsung Bioepis            
Derivatives [Line Items]            
Equity, ownership interest 49.90%   49.90%     49.90%